Liver cancer screening among patients with cirrhosis almost doubled when they were mailed a signed order from their specialist, according to a new study from the Perelman School of Medicine at the University of Pennsylvania. ...
Dec 22, 2023
0
0
A new treatment strategy for locally advanced liver cancer, known as "reduce and remove," was announced by the Department of Surgery and Department of Clinical Oncology, Center of Cancer Medicine, School of Clinical Medicine, ...
Dec 14, 2023
0
35
Liver cancer rates have more than tripled in the U.S. since 1980 and continue to rise. More than 41,000 people will be diagnosed with liver cancer in the U.S. this year, and about 29,000 will die from the disease, according ...
Dec 13, 2023
0
0
Non-alcoholic fatty liver disease (NAFLD), characterized by excessive hepatic lipid accumulation, poses a high prevalence and can progress to cirrhosis and liver cancer. To enhance preventive and therapeutic efforts, an in-depth ...
Dec 11, 2023
0
0
The global rise in obesity and diabetes is leading to an epidemic in fatty liver disease affecting 20%–30% of the world's population. Almost a third of people with fatty liver disease go on to develop an advanced form of ...
Dec 7, 2023
0
0
A breakthrough in the understanding of the relationship between a naturally occurring enzyme and the liver cancer drug sorafenib could improve the effectiveness of the drug, which currently prolongs the life of liver cancer ...
Dec 4, 2023
0
53
Researchers at UC Davis Comprehensive Cancer Center have shown that inhibiting a specific protein using gene therapy can shrink hepatocellular carcinoma (HCC) in mice. Silencing the galectin 1 (Gal1) protein, which is often ...
Nov 30, 2023
0
0
In the United States, liver cancer rates have more than tripled since 1980. Some groups, including Latinos, face an even higher risk than the general population—but researchers do not fully understand why.
Nov 20, 2023
0
0
An overwhelming majority of hepatocellular carcinoma occurs in people already suffering from cirrhosis of the liver.
Nov 14, 2023
0
0
A drug that can halve the risk of developing breast cancer in post-menopausal women has been approved for use in the UK. This drug, called anastrozole, could benefit an estimated 289,000 women in the UK who are at increased ...
Nov 9, 2023
0
0
